Live shingles vaccine shows safe, short-term efficacy for persons taking TNFis for inflammatory diseases

A randomized controlled trial found that the live shingles, or varicella-zoster, vaccine was safe and showed short-term efficacy for participants also taking tumor necrosis factor inhibitors (TNFis) for a broad range of inflammatory disorders. These finding suggest that a live virus vaccine in immunosuppressed patients receiving biologic therapies may be a reasonable option, especially for the zoster vaccine, if no alternative vaccine is available. The findings are published in Annals of Internal Medicine.

source https://medicalxpress.com/news/2021-09-shingles-vaccine-safe-short-term-efficacy.html